DoD Reconstructive Transplant, Investigator Initiated Research Award | W81XWH 21 RTRP IIRA

FY21 DoD RTRP Investigator-Initiated Research Award (IIRA) FAQs

What is the FY21 DoD Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award (IIRA)?

The FY21 DoD RTRP Investigator-Initiated Research Award (IIRA) is a Department of Defense funding opportunity intended to advance reconstructive transplantation research in ways that can meaningfully improve patient care and quality of life. It supports innovative, investigator-driven studies that are still expected to be well-justified, carefully planned, and connected to practical outcomes that matter to patients.

What is the main goal of this award?

The goal is to fund research that can make a significant contribution to reconstructive transplant science while maintaining a strong scientific foundation, a rigorous and reproducible study plan, and a clear path toward real-world usefulness and translation.

What kinds of projects does the IIRA aim to support?

The mechanism emphasizes innovative and potentially groundbreaking ideas, but the proposal must be feasible and built on a rigorous, reproducible approach. Reviewers are looking for clearly defined objectives, appropriate methods, and planning that supports replication or extension by other researchers.

What does the program mean by strong study design and feasibility?

Applicants are expected to present a clear and rigorous approach that is designed for reproducibility and has a realistic path toward translation. This includes well-defined objectives, appropriate and thoughtful methods, and consideration of how the work could be replicated or extended.

Is a statistical plan or power analysis required?

Where it fits the project, applicants should include a statistical plan and a power analysis to show that the study is appropriately sized and structured to produce interpretable results, rather than findings that are purely exploratory and difficult to act on.

How important is impact in this funding opportunity?

Impact is a core requirement. Applications need to describe both short-term and long-term value, including how the work could advance reconstructive transplant science, address barriers to care, improve functional outcomes, influence clinical practice, or improve patient well-being over time.

Do proposed projects have to align with specific priorities or focus areas?

Yes. Projects must align with at least one of the FY21 IIRA Focus Areas under the RTRP. A project is not considered responsive simply because it is novel or interesting; it must clearly connect to the program's FY21 priorities.

Is military relevance required?

Yes. Military relevance is required and treated as a defining feature of the opportunity. The research should be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injuries, and may also benefit their families, caregivers, and clinicians.

Is collaboration with military researchers or clinicians required?

Collaboration with military researchers and clinicians is encouraged but not mandatory. Even without a military collaborator, the application must make a convincing case that the knowledge gained will be applicable to the populations and clinical challenges the DoD is focused on.

What kinds of real-world needs should the military relevance address?

The proposal should demonstrate applicability to issues commonly encountered after traumatic injury and complex reconstruction, where reconstructive transplantation approaches may be relevant, and explain how the research could help address those challenges.

Are preliminary data required for an application?

For most Focus Areas, the program expects applicants to include preliminary and/or published data that directly support the rationale for the proposed work and show the project is grounded in evidence and ready for investment.

Are there any exceptions to the preliminary data expectations?

Yes. The Focus Area titled "Retrospective studies of VCA" (vascularized composite allotransplantation) treats the preliminary data requirement differently, reflecting the nature of retrospective research.

What sources of preliminary evidence does the program recognize?

The program recognizes that early observations can come from multiple sources, including laboratory discoveries, population-based studies, clinical experience, and anecdotal signals that help inspire a research question. However, for most Focus Areas, preliminary and/or published data are still expected to directly support the project rationale.

What types of research are allowed under the IIRA mechanism?

The IIRA is broad across the research pipeline and supports basic through translational studies. This can include preclinical studies using animal models, research involving human subjects or human anatomical substances, and correlative studies tied to an existing clinical trial.

Are clinical trials allowed under this award?

No. A clinical trial cannot be conducted under this award.

How does this opportunity define a clinical trial?

The opportunity uses the standard definition of a clinical trial: any study in which one or more human subjects are prospectively assigned to one or more interventions (including placebo or controls) to evaluate the effects on biomedical or behavioral health-related outcomes.

Can a project include human subjects research if it is not a clinical trial?

Yes. Human-focused research is allowed as long as it does not meet the definition of a clinical trial under this opportunity (for example, it cannot involve prospective assignment of human subjects to interventions to evaluate outcomes).

Can an application propose correlative studies related to an existing clinical trial?

Yes. Correlative studies tied to an existing clinical trial are listed as an allowable type of research, as long as the proposed work itself is not a clinical trial under the award's definition.

Who manages this funding opportunity?

This is a discretionary Department of Defense opportunity managed through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA).

What is the funding opportunity number?

The funding opportunity number is W81XWH-21-RTRP-IIRA.

What types of awards are supported (grant vs. cooperative agreement)?

The opportunity supports awards through grants and cooperative agreements.

Who is eligible to apply?

Eligibility is listed as unrestricted, meaning it is open to a wide range of applicant organizations, subject to any additional eligibility details provided in the full announcement.

When was this opportunity created and what was the closing date listed?

The opportunity was created on August 4, 2021, and the original closing date was December 8, 2021.

How many awards were expected?

The listing noted an expectation of about seven awards.

What was the award ceiling?

The summary data showed an award ceiling of 0, which commonly suggests the ceiling was not captured in the abbreviated record and that applicants should rely on the full program announcement for budget limits and related details.

What is the CFDA number associated with this opportunity?

The CFDA number associated with the program is 12.420, aligning it with DoD research and development assistance activities.